文献速递神经肿瘤神经重症

坐位小脑上经小丘入路切除中脑导水管血管母细胞瘤

Hemangioblastoma of Cerebral Aqueduct Removed via Sitting, Supracerebellar Intracollicular Approach.
PubMed 文献 · World Neurosurg · 2019-03-28

本文报告一例65岁男性因脑积水症状就诊,影像发现中脑导水管内强化结节,6个月内明显增大后接受手术。采用坐位小脑上经小丘入路实现肿瘤全切,无并发症,病理为血管母细胞瘤,术后2年无神经功能缺损。

要点

  • 中脑导水管内肿瘤罕见,本例为首例报道的导水管血管母细胞瘤。
  • 坐位小脑上经小丘入路可安全到达导水管内肿瘤并实现全切。
  • 术后2年随访患者状态良好,无神经功能缺损。

核心结论

  • 采用坐位小脑上经小丘入路可成功全切中脑导水管内血管母细胞瘤,术后2年无神经功能缺损。

研究设计与样本

  • 个案报道:1例65岁男性中脑导水管血管母细胞瘤患者。

主要发现

  • 患者因脑积水症状就诊,初始影像显示中脑导水管内小强化结节。
  • 初始影像后6个月内肿瘤明显增大,遂行手术切除。
  • 坐位小脑上经小丘入路实现肿瘤全切,无并发症。
  • 病理诊断为血管母细胞瘤,术后2年患者状态良好、无神经功能缺损。

临床怎么用

  • 对于中脑导水管内占位,可考虑坐位小脑上经小丘入路进行手术切除。
  • 术前需评估肿瘤生长速度,本例在6个月内明显增大。

局限性

  • 仅为单例个案报道,结论推广需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumors protruding into the cerebral aqueduct are rare, and tumors arising from within the cerebral aqueduct are rarer still. CASE DESCRIPTION: In this report, we discuss the presentation and clinical outcome of a 65-year-old man who presented to us with symptoms of hydrocephalus. Prior imaging had revealed a small enhancing nodule within the cerebral aqueduct. In the 6 months between initial imaging and our seeing the patient, the tumor demonstrated substantial interval growth, so the patient was offered resection. The tumor was accessed using a sitting, supracerebellar, intracollicular approach, which allowed for gross total resection of the mass without complication. Histopathology later revealed the lesion to be a hemangioblastoma. Two years after surgery, the patient was doing well with no neurologic deficits. CONCLUSIONS: We report the first case of an aqueductal hemangioblastoma and describe our use of a sitting, supracerebellar, intracollicular approach to access tumors occupying this cerebrospinal fluid space.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Briggs RG, Jones RG, Conner AK, et al. Hemangioblastoma of Cerebral Aqueduct Removed via Sitting, Supracerebellar Intracollicular Approach. World Neurosurg. 2019. PMID: 30928590. doi:10.1016/j.wneu.2019.03.206

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。